New pill aims to stop dangerous platelet drop in breast cancer treatment
Prevention
Not yet recruiting
This study tests whether the drug herombopag can prevent low platelet counts (thrombocytopenia) in people with HER2-positive breast cancer receiving T-DM1 therapy. Low platelets are common in Asian patients and can cause bleeding or force treatment delays. About 45 participants w…
Phase: NA • Sponsor: Zhenzhen Liu • Aim: Prevention
Last updated May 17, 2026 05:09 UTC